OLIGOMERIX

Oligomerix is a biopharmaceutical company founded in 2006 by co-founders Eliot J. Davidowitz and James Moe. The Company is exploiting its novel research that allows rapid generation of stable amyloid oligomers as targets for drug discovery. These systems will enable target identification and validation, and drug discovery for Alzheimer's and other neurodegenerative diseases.

OLIGOMERIX

Social Links:

Twitter

Industry:

Biotechnology Ediscovery Medical

Founded:

2006-01-01

Address:

Bronx, New York, United States

Country:

United States

Website Url:

http://www.oligomerix.com

Total Employee:

Status:

Active

Contact:

(212) 568-0365

Email Addresses:

[email protected]

Total Funding:

15.13 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress

Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

Current Employees Featured

james-moe_image

James Moe
James Moe Co-Founder & CEO , Director, Principal Investigator @ Oligomerix
Co-Founder & CEO , Director, Principal Investigator

not_available_image

Eliot J. Davidowitz
Eliot J. Davidowitz Co-Founder @ Oligomerix
Co-Founder

not_available_image

Vic Micati
Vic Micati Chairman @ Oligomerix
Chairman

not_available_image

Jack Pasini
Jack Pasini CCO @ Oligomerix
CCO

Founder

not_available_image

Eliot J. Davidowitz

james-moe_image

James Moe

Investors List

national-institutes-of-health_image

Official Site Inspections

http://www.oligomerix.com

Host Informations
Whois Informations

Loading ...